Related Experiment Videos
Unsupervised immunophenotypic profiling of chronic lymphocytic leukemia.
Luzette K Habib1, William G Finn
1Department of Pathology, University of Michigan Medical School, Ann Arbor, 48109, USA.
Cytometry. Part B, Clinical Cytometry
|February 25, 2006
Summary
Unsupervised analysis of flow cytometry data revealed distinct subtypes of B-cell chronic lymphoproliferative disorders. This approach offers a proteomic-like method for disease classification beyond traditional validation.
Area of Science:
- Immunology
- Computational Biology
- Oncology
Background:
- Proteomics and functional genomics advance disease classification.
- Flow cytometry (FCM) analyzes protein expression on intact cells.
- FCM traditionally validates markers or predicts outcomes, not for unsupervised discovery.
Purpose of the Study:
- To assess feasibility of unsupervised cluster analysis for FCM data.
- To explore FCM as a cell-based proteomic approach for disease classification.
Main Methods:
- Retrospective analysis of multicolor FCM data from 140 patients with B-cell chronic lymphoproliferative disorders.
- Hierarchical cluster analysis of peripheral blood and bone marrow lymphocyte data.
- Normalized expression of CD19 and 10 additional B-cell markers.
Main Results:
- Three major clusters identified in chronic lymphocytic leukemia (CLL) peripheral blood samples.
- One cluster showed "atypical" CLL markers (high CD20, CD22, FMC7, light chain; low CD23).
- Two clusters of "typical" BCLL distinguished by CD38, CD20, and CD23 expression, with a trend toward survival differences.
Conclusions:
- Unsupervised immunophenotypic profiling of FCM data can identify reproducible lymphoma/leukemia subtypes.
- FCM shows potential as an unsupervised class discovery tool, similar to proteomic methods.
- Further studies are warranted to establish FCM as a primary discovery tool.